YOU ARE HERE:
Starting treatment news
page  of 18
 
Headline
Date
  New EACS guidelines address co-morbidities and diseases of age
16.11.09
  Protease inhibitor monotherapy as a maintenance regimen: are we edging towards acceptance?
16.11.09
  Cost-effective ways to reduce loss to follow-up in ART programmes identified
28.10.09
  FDA committee recommends approval of maraviroc for first-line treatment in US
09.10.09
  CD4 cell count below 500 increases cancer risk for patients with HIV
08.10.09
  Virologic response to HIV treatment differs by race among US patients
07.10.09
  Majority of patients lost to follow-up still alive one year later, Ugandan study shows
02.10.09
  Inflammation signals heart disease risk in people with HIV
23.09.09
  Raltegravir approved for first-line use in European Union
15.09.09
  HIV treatment may induce protective immunity in brain, monkey study finds
14.09.09
  Early treatment and interruption makes no difference to disease progression, study finds
04.09.09
  d4T dose reduction does not result in poorer treatment outcomes in South African patients
04.09.09
  Clinical officers and nurses make similar decisions to physicians on starting antiretroviral therapy in rural Uganda
03.09.09
  Uganda survey shows major ART training gaps for non-physicians
01.09.09
  Study suggests immune systems of untreated HIV-infected individuals may deteriorate faster than previously thought
12.08.09
  Ten steps to reducing loss to follow up
11.08.09
  Abacavir as potent as tenofovir for patients starting HIV treatment with a high viral load
06.08.09
  Nevirapine matches atazanavir/ritonavir in 48-week study
29.07.09
  Genotypic tests matches tropism test in predicting who benefits from CCR5 inhibitors
28.07.09
  Aciclovir reduces disease progression and death in people with HIV by nearly 20 per cent
23.07.09

page  of 18